Inventor · disambiguated record
Abdelsattar M. Omar
Also filed as: OMAR ABDELSATTAR · OMAR ABDELSATTAR M · OMAR ABDELSATTAR MANSOUR · OMAR ABDELSATTAR MANSOUR EBEID
47 granted patents·5 pending applications·46 citations·filing 2016–2024
97Inventor score
Files withUNIV KING ABDULAZIZ45UNIV VIRGINIA COMMONWEALTH4ALREEMI ROAA M1BARADWAN MOHAMMED A1UNIV OF JEDDAH1
Top patents by PatentIndex Score
52 records- 0197US10836729B1Metabolically stable 5-HMF derivatives for the treatment of hypoxiaUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 17, 2020·4 cites·4 claims
- 0294US10836736B1Pharmaceutical composition with cytotoxic activity on colorectal cancer cellsUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 17, 2020·7 cites·3 claims
- 0392US11325885B2Method for treating stomach cancerUNIV KING ABDULAZIZ·Filed 2021·Granted May 10, 2022·1 cites·2 claims
- 0491US11214537B2Method for making anti-cancer compoundsUNIV KING ABDULAZIZ·Filed 2021·Granted Jan 4, 2022·1 cites·4 claims
- 0590US11319292B2Metabolically stable 5-HMF derivatives for the treatment of hypoxiaUNIV KING ABDULAZIZ·Filed 2021·Granted May 3, 2022·1 cites·4 claims
- 0690US11186597B1Method of extracting phospholipids from fish roeUNIV KING ABDULAZIZ·Filed 2021·Granted Nov 30, 2021·3 cites·13 claims
- 0790US11136288B2Method for treating a patient having cancerUNIV KING ABDULAZIZ·Filed 2021·Granted Oct 5, 2021·1 cites·7 claims
- 0889US11312680B2Method for treating a patient having a colon cancerUNIV KING ABDULAZIZ·Filed 2021·Granted Apr 26, 2022·1 cites·2 claims
- 0989US11142493B1Pharmaceutical composition for treating cancerUNIV KING ABDULAZIZ·Filed 2021·Granted Oct 12, 2021·1 cites·3 claims
- 1087US11220485B2Chemotherapeutic oxazolone derivatives and pharmaceutical compositions thereofUNIV KING ABDULAZIZ·Filed 2021·Granted Jan 11, 2022·1 cites·3 claims
- 1185US11648248B1Potent antimicrobial compounds with a pyridazine nucleusUNIV KING ABDULAZIZ·Filed 2022·Granted May 16, 2023·3 cites·7 claims
- 1284US10813882B1In situ gelling formulation for reduced initial drug burstUNIV KING ABDULAZIZ·Filed 2019·Granted Oct 27, 2020·3 cites·3 claims
- 1384US10709662B1Mucoadhesive buccal film having a dual release carrier systemUNIV KING ABDULAZIZ·Filed 2020·Granted Jul 14, 2020·2 cites·9 claims
- 1483US11104632B1Metabolically stable vanillin derivatives for the treatment of hypoxiaUNIV KING ABDULAZIZ·Filed 2020·Granted Aug 31, 2021·1 cites·4 claims
- 1583US10844022B1Pharmaceutical composition and method of treating cancerUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 24, 2020·1 cites·2 claims
- 1683US10744137B1Liquisolid tablet containing combined dose of tadalafil and dapoxetineUNIV KING ABDULAZIZ·Filed 2020·Granted Aug 18, 2020·2 cites·13 claims
- 1783US10653634B1Polymeric nanoparticulate formulation to enhance the oral bioavailability of dapoxetineUNIV KING ABDULAZIZ·Filed 2019·Granted May 19, 2020·2 cites·13 claims
- 1881US10973760B1Instantly dissolving buccal filmsUNIV KING ABDULAZIZ·Filed 2020·Granted Apr 13, 2021·1 cites·8 claims
- 1980US11180458B2Anticancer compounds, pharmaceutical compositions thereof, and a method of treating cancerUNIV KING ABDULAZIZ·Filed 2019·Granted Nov 23, 2021·1 cites·11 claims
- 2080US11058637B1Surface-modified emulsomes for intranasal delivery of drugsUNIV KING ABDULAZIZ·Filed 2020·Granted Jul 13, 2021·1 cites·4 claims
- 2180US10988439B2Cytotoxic compounds, pharmaceutical compositions thereof, and methods of treating cancerUNIV KING ABDULAZIZ·Filed 2019·Granted Apr 27, 2021·1 cites·6 claims
- 2280US10882852B13-vinylquinolines as cancer cells inhibitorsUNIV KING ABDULAZIZ·Filed 2020·Granted Jan 5, 2021·1 cites·3 claims
- 2379US12065408B2Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell diseaseUNIV VIRGINIA COMMONWEALTH·Filed 2023·Granted Aug 20, 2024·0 cites·11 claims
- 2478US11479536B1Arylacetamides as AMP-activated protein kinase inhibitors and their use for treatment of breast cancerUNIV KING ABDULAZIZ·Filed 2022·Granted Oct 25, 2022·1 cites·4 claims
- 2578US10821096B1Compounds for inhibiting NS3 and compositions containing the inhibited proteinUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 3, 2020·1 cites·5 claims
- 2678US10344001B2Azolylacryloyl derivatives as therapeutic agents for sickle cell diseaseUNIV VIRGINIA COMMONWEALTH·Filed 2016·Granted Jul 9, 2019·3 cites·2 claims
- 2777US11174233B1Anti-cancer compounds having oxazolone derivationUNIV KING ABDULAZIZ·Filed 2021·Granted Nov 16, 2021·0 cites·3 claims
- 2877US10959987B2Imidazole-based compounds as hepatitis C virus inhibitorsUNIV KING ABDULAZIZ·Filed 2019·Granted Mar 30, 2021·1 cites·20 claims
- 2974US11214556B1Method of treating colorectal cancerUNIV KING ABDULAZIZ·Filed 2021·Granted Jan 4, 2022·0 cites·2 claims
- 3074US10844007B1Amide group-containing compounds and use for cancer treatmentUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 24, 2020·0 cites·9 claims
- 3174US2025019349A1Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell diseaseUNIV VIRGINIA COMMONWEALTH·Filed 2024·Application pending·0 cites
- 3273US11312694B2Method for making propenamide compoundUNIV KING ABDULAZIZ·Filed 2021·Granted Apr 26, 2022·0 cites·2 claims
- 3369US11155528B2Bis-propenamide compounds and methods of treating cancerUNIV KING ABDULAZIZ·Filed 2019·Granted Oct 26, 2021·0 cites·2 claims
- 3468US11149012B1Metabolically stable 5-HMF derivatives for the treatment of hypoxiaUNIV KING ABDULAZIZ·Filed 2020·Granted Oct 19, 2021·0 cites·2 claims
- 3564US12285418B12-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of acute myeloid leukemiaUNIV OF JEDDAH·Filed 2024·Granted Apr 29, 2025·0 cites·4 claims
- 3664US11345692B13-vinylquinolines as cancer cells inhibitorsUNIV KING ABDULAZIZ·Filed 2020·Granted May 31, 2022·0 cites·10 claims
- 3764US10668020B1Pullulan based vinpocetine tablets, lyoplant-tabs, as a buccal solid dosage formUNIV KING ABDULAZIZ·Filed 2019·Granted Jun 2, 2020·0 cites·14 claims
- 3863US10683267B1Antidiabetic compoundsUNIV KING ABDULAZIZ·Filed 2019·Granted Jun 16, 2020·0 cites·3 claims
- 3962US11234933B1Surface-modified emulsomes for intranasal delivery of drugsUNIV KING ABDULAZIZ·Filed 2021·Granted Feb 1, 2022·0 cites·2 claims
- 4061US2025282764A1Imidazole heterocycle based compounds and methods of treating cancerUNIV KING ABDULAZIZ·Filed 2024·Application pending·0 cites
- 4161US2024109843A1Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell diseaseUNIV VIRGINIA COMMONWEALTH·Filed 2023·Application pending·0 cites
- 4260US11147765B1Instantly dissolving buccal filmsUNIV KING ABDULAZIZ·Filed 2021·Granted Oct 19, 2021·0 cites·12 claims
- 4360US10654800B1Antidiabetic compoundsUNIV KING ABDULAZIZ·Filed 2020·Granted May 19, 2020·0 cites·19 claims
- 4457US2020369727A1Composition and method for treating a patient having liver cirrhosisUNIV KING ABDULAZIZ·Filed 2020·Application pending·0 cites
- 4556US12404246B12-aminomethylimidazole mimics of NS4A and their effect thereof on hepatitis C virus NS3 proteaseBARADWAN MOHAMMED A·Filed 2024·Granted Sep 2, 2025·0 cites·10 claims
- 4655US10888566B1Chemosensitization of resistant Pseudomonas aeruginosa by synthetically related compoundsUNIV KING ABDULAZIZ·Filed 2020·Granted Jan 12, 2021·0 cites·10 claims
- 4755US10842795B1Chemosensitization of resistant Pseudomonas aeruginosa by synthetically related compoundsUNIV KING ABDULAZIZ·Filed 2020·Granted Nov 24, 2020·0 cites·8 claims
- 4854US12258321B1Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancerALREEMI ROAA M·Filed 2024·Granted Mar 25, 2025·0 cites·6 claims
- 4954US2020308228A1Peptide inhibitors of hcv ns3/4a protease comprising non-proteinogenic amino residuesUNIV KING ABDULAZIZ·Filed 2019·Application pending·0 cites
- 5053US11298321B1Methods for treating metabolic disorderUNIV KING ABDULAZIZ·Filed 2021·Granted Apr 12, 2022·0 cites·13 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →